Hog futures fall on tariff worries, technical selling - CME

Mar 17, 2025

Chicago Mercantile Exchange (CME) lean hog futures edged down on Thursday under pressure from technical selling and worries that US President Donald Trump's tariff war could hurt export demand, Reuters reported, citing analysts.

The European Union announced has a plan to impose duties on US imports, including on poultry and meat products.

"The market is worried about what will happen with the EU," Doug Houghton, analyst at Brock Associates, said.

CME's April lean hog contract settled down 0.875-cent to 85.625 cents per pound.

Live and feeder cattle futures spent the day chopping up and down as a lack of fresh news provided little direction for the futures.

CME April live cattle rose 0.65-cent at 202.05 cents per pound. CME April feeder cattle futures settled down 0.75-cent to 279.975 cents per pound.

Click here to see more...

Video: New Solution Powers Efficient Pork Growth

Alltech has introduced Olerix, an innovative phytogenic blend created to promote growth and feed efficiency in pigs. Through a proprietary coating process, the bioactive blend of phytogenic compounds used in Olerix is designed to outlast the manufacturing process, ensuring consistent outcomes from feed to finish. The result is a high-impact efficiency solution that provides consistent support for gut health, feed efficiency, immune function and growth performance. Olerix is backed by validated trials conducted under modern pork production conditions.

“As the industry searches for technology to drive profitability forward in a more sustainable manner, we’re thrilled to join that effort with our Olerix technology,” said Mark Hulsebus, general manager for U.S. pork at Alltech. “Our work in this phytogenic space is yielding very encouraging results, and we’re excited to make this new opportunity available to pork producers focused on optimizing feed efficiency and growth rates.”

“Olerix represents the next generation of phytogenic technology — combining feed efficiency, livability and immune support into a practical commercial solution producers can implement today,” said Andy Rash, U.S. monogastric director at Alltech.